Literature DB >> 28863203

PURLs: SSRIs for depression/heart failure patients? Not so fast.

Jason Ricco1, Janice Benson2, Shailendra Prasad1.   

Abstract

This study should put to rest the practice of starting SSRIs in depressed patients with heart failure in an attempt to affect CVD outcomes.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28863203      PMCID： PMC5597340     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  14 in total

1.  Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.

Authors:  Christopher M O'Connor; Wei Jiang; Maragatha Kuchibhatla; Susan G Silva; Michael S Cuffe; Dwayne D Callwood; Bosh Zakhary; Wendy Gattis Stough; Rebekka M Arias; Sarah K Rivelli; Ranga Krishnan
Journal:  J Am Coll Cardiol       Date:  2010-08-24       Impact factor: 24.094

Review 2.  Relationships between positive psychological constructs and health outcomes in patients with cardiovascular disease: A systematic review.

Authors:  Christina M DuBois; Oriana Vesga Lopez; Eleanor E Beale; Brian C Healy; Julia K Boehm; Jeff C Huffman
Journal:  Int J Cardiol       Date:  2015-05-21       Impact factor: 4.164

3.  Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction.

Authors:  C Barr Taylor; Marston E Youngblood; Diane Catellier; Richard C Veith; Robert M Carney; Matthew M Burg; Peter G Kaufmann; John Shuster; Thomas Mellman; James A Blumenthal; Ranga Krishnan; Allan S Jaffe
Journal:  Arch Gen Psychiatry       Date:  2005-07

4.  Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes.

Authors:  Thomas Rutledge; Veronica A Reis; Sarah E Linke; Barry H Greenberg; Paul J Mills
Journal:  J Am Coll Cardiol       Date:  2006-09-26       Impact factor: 24.094

Review 5.  Depression and cardiovascular disorders.

Authors:  Mary A Whooley; Jonathan M Wong
Journal:  Annu Rev Clin Psychol       Date:  2013       Impact factor: 18.561

6.  Effect of Escitalopram on All-Cause Mortality and Hospitalization in Patients With Heart Failure and Depression: The MOOD-HF Randomized Clinical Trial.

Authors:  Christiane E Angermann; Götz Gelbrich; Stefan Störk; Hilka Gunold; Frank Edelmann; Rolf Wachter; Heribert Schunkert; Tobias Graf; Ingrid Kindermann; Markus Haass; Stephan Blankenberg; Sabine Pankuweit; Christiane Prettin; Martin Gottwik; Michael Böhm; Hermann Faller; Jürgen Deckert; Georg Ertl
Journal:  JAMA       Date:  2016-06-28       Impact factor: 56.272

7.  Cognitive Behavior Therapy for Depression and Self-Care in Heart Failure Patients: A Randomized Clinical Trial.

Authors:  Kenneth E Freedland; Robert M Carney; Michael W Rich; Brian C Steinmeyer; Eugene H Rubin
Journal:  JAMA Intern Med       Date:  2015-11       Impact factor: 21.873

8.  Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial.

Authors:  Lisa F Berkman; James Blumenthal; Matthew Burg; Robert M Carney; Diane Catellier; Marie J Cowan; Susan M Czajkowski; Robert DeBusk; James Hosking; Allan Jaffe; Peter G Kaufmann; Pamela Mitchell; James Norman; Lynda H Powell; James M Raczynski; Neil Schneiderman
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

9.  Direction of Association Between Depressive Symptoms and Lifestyle Behaviors in Patients with Coronary Heart Disease: the Heart and Soul Study.

Authors:  Nancy L Sin; Anupama D Kumar; Anil K Gehi; Mary A Whooley
Journal:  Ann Behav Med       Date:  2016-08

Review 10.  Screening and management of depression for adults with chronic diseases: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2013-09-01
View more
  1 in total

1.  Three-dimensional morphometric analysis reveals time-dependent structural changes in microglia and astrocytes in the central amygdala and hypothalamic paraventricular nucleus of heart failure rats.

Authors:  Ferdinand Althammer; Hildebrando Candido Ferreira-Neto; Myurajan Rubaharan; Ranjan K Roy; Atit A Patel; Anne Murphy; Daniel N Cox; Javier E Stern
Journal:  J Neuroinflammation       Date:  2020-07-23       Impact factor: 8.322
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.